Novo Says Still Some Uncertainty on Tresiba Costs

Oct. 31 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about the company's third-quarter profit reported today, sales forecast and the launch of its new diabetes treatment, Tresiba. He speaks from Bagsvaerd, Denmark, with Caroline Hyde on Bloomberg Television's "The Pulse." (Source: Bloomberg)
The Top Stocks to Watch in Asia Today
22:07 - In today’s “Stock Exchange,” Bloomberg’s Yvonne Man and Shery Ahn discuss the top stocks to watch in Asia on “First Up.” (Source: Bloomberg)
  • Japanese Market Is Showing Signs of Life: Dagan
  • Hanergy's Li Increased Short Position Before Stock Crash
  • Greece Calls on Creditors to Compromise